Abstract:ABSTRACT Aims Thyroid hormones impact lipid metabolism and glucose homoeostasis through both central and peripheral regulation; however, little research has delved into the association between thyroid hormone sensitivity and metabolically obese phenotypes. We aimed to investigate the correlation between indices of central and peripheral sensitivity to thyroid hormones and metabolically obese phenotypes in euthyroid Chinese adults. Methods This cross‐sectional study included 20,084 euthyroid individuals. Central thyroid hormone sensitivity was assessed using the thyroid feedback quantile‐based index (TFQI), parametric thyroid feedback quantile‐based index (PTFQI), thyroid‐stimulating hormone index (TSHI), and thyrotropin thyroxine resistance index (TT4RI), while peripheral thyroid hormone sensitivity was measured by FT3/FT4. Metabolically obesity phenotypes included metabolically healthy non‐obesity (MHNO), unhealthy non‐obesity (MUNO), metabolically healthy obesity (MHO), and unhealthy obesity (MUO). Multinomial logistic regression and restricted cubic spline analyses were conducted to investigate the association between thyroid hormone sensitivity indices and metabolically obese phenotypes risk. Subgroup analysis was also performed to examine this association stratified by sex and age. Mediation analysis was performed to estimate direct and indirect effects of BMI. Results Prevalence of MHNO, MUNO, MHO and MUO was 66.1% ( n = 13,273), 21.3% ( n = 4271), 5.3% ( n = 1055), and 7.4% ( n = 1485) respectively. After adjustment for potential confounders, the odds ratios (ORs) (95% CI) for MUNO and MUO were increased with all elevated thyroid hormones sensitivity indices (per SD increase) [MUNO: TFQI 1.14(1.09–1.19), PTFQI 1.18(1.23–1.23); TSHI 1.26(1.19–1.33), TT4RI 1.41, (1.31–1.53), FT3/FT4 1.20(1.14–1.25) and [MUO: TFQI 1.20(1.11–1.31), PTFQI 1.26(1.16–1.37), TSHI 1.39 (1.26–1.54), TT4RI 1.70(1.48–1.95), FT3/FT4 1.26 (1.16–1.37)] ( p value < 0.001), and only TSHI and TT4RI (per SD increase) significantly increased the risk of MHO (TSHI: OR = 1.12, 95% CI 1.01–1.24; TT4RI: OR = 1.25, 95%CI 1.08–1.4) ( p value < 0.05). Non‐linear relationships were observed between central thyroid hormones sensitivity indices and MUNO and MUO( p for nonlinearity < 0.05). Conversely, a linear relationship between FT3/FT4 and metabolically obese phenotypes was noted in all subjects ( p for nonlinearity > 0.05). Besides, subgroup analysis indicated that this association remained consistent among sex and age ( p for interaction > 0.05). The proportions mediated by BMI on the association of TFQI, PTFQI, TSHI, TT4RI, FT3/FT4 and risk of metabolically unhealthy conditions were 13.73%, 25.38%, 22.75%, 17.94% and 62.28%, respectively. Conclusions In euthyroid adults, central and peripheral sensitivity to thyroid hormones indices are positively associated with metabolically obese phenotypes risk, especially MUNO and MUO phenotypes.

Characteristics of Serum Thyroid Hormones in Different Metabolic Phenotypes of Obesity

Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study

Association between different metabolic phenotypes of obesity and thyroid disorders among Chinese adults: a nationwide cross-sectional study

The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults

Association Between Serum Thyrotropin Within The Euthyroid Range And Obesity

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity

High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker

Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy

Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid population

Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity

Exploring the link between obesity and hypothyroidism in autoimmune thyroid diseases: a metabolic perspective

Association between Abdominal Fat Distribution and Free Triiodothyronine in a Euthyroid Population

A comprehensive metabolic profiling of the metabolically healthy obesity phenotype

The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study

Insulin resistance persists despite a metabolically healthy obesity phenotype

Correlation between Thyroid Homeostasis and Obesity in Subclinical Hypothyroidism: Community-Based Cross-Sectional Research

The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population.

Metabolically healthy obesity: Misleading phrase or healthy phenotype?

1236-P: Cardiometabolic Disease Risk in Metabolically Unhealthy vs. Healthy in Normal Weight and Obesity: Results from 2015 and 20KNHNES Data

Fat-Free Mass, Metabolically Healthy Obesity, and Type 2 Diabetes in Severely Obese Asian Adults